Federal Register / Vol. 86, No. 22 / Thursday, February 4, 2021 / Notices 8203 

lines 2–3, change ‘‘Am. J. Physiol. Lung 

Cell. Mol. Biol.’’ to ‘‘Am. J. Resp. Cell. 

Mol. Biol.’’ 

5. On page 60098, second column, in 

FR Doc. 2019–24291, sixth paragraph, 

lines 1 and 3, change ‘‘J. App. Physiol.’’ 

to ‘‘J. Appl. Physiol.’’ 

6. On page 60098, second column, in 

FR Doc. 2019–24291, twenty-third 

paragraph, lines 1–2, change ‘‘Am. J. 

Physiol. Lung Cell. Mol. Biol. 2011b 

paper’’ to ‘‘Am. J. Physiol. Lung Cell. 

Mol. Physiol. 2011;301(3):L327–L333.’’ 

Dated: January 29, 2021. 

Wanda K. Jones, 

Acting Director, Office of Research Integrity. 

[FR Doc. 2021–02272 Filed 2–3–21; 8:45 am] 

BILLING CODE 4150–31–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Office of the Secretary 

Findings of Research Misconduct 

AGENCY: Office of the Secretary, HHS. 

ACTION: Notice. 

SUMMARY: Findings of research 

misconduct have been made against 

Yibin Lin, Ph.D. (Respondent), former 

postdoctoral fellow, McGovern Medical 

School, University of Texas Health 

Science Center (UTHealth). Respondent 

engaged in research misconduct in 

research supported by U.S. Public 

Health Service (PHS) funds, specifically 

National Institute of Allergy and 

Infectious Diseases (NIAID), National 

Institutes of Health (NIH), grant R01 

AI125216. The administrative actions, 

including debarment for a period of ten 

(10) years, were implemented beginning 

on January 7, 2021, and are detailed 

below. 

FOR FURTHER INFORMATION CONTACT: 

Wanda K. Jones, Dr. P.H., Acting 

Director, Office of Research Integrity, 

1101 Wootton Parkway, Suite 240, 

Rockville, MD 20852, (240) 453–8200. 

SUPPLEMENTARY INFORMATION: Notice is 

hereby given that the Office of Research 

Integrity (ORI) has taken final action in 

the following case: 

Yibin Lin, Ph.D., University of Texas 

Health Science Center: Based on the 

report of an assessment conducted by 

UTHealth, Respondent’s admission, and 

analysis conducted by ORI in its 

oversight review, ORI found that Dr. 

Yibin Lin, former postdoctoral fellow, 

McGovern Medical School, UTHealth, 

engaged in research misconduct in 

research supported by PHS funds, 

specifically NIAID, NIH, grant R01 

AI125216. 

ORI found that Respondent engaged 

in research misconduct by knowingly 

and intentionally falsifying, fabricating, 

and plagiarizing data and text reported 

in the following published papers, 

which have been retracted, and 

manuscripts: 

Published Papers 

• Efficient Method for Genomic DNA 

Mutagenesis in E. coli. bioRxiv 2020. 

doi: https://doi.org/10.1101/ 

2020.05.16.097097. 

• A simple and efficient method for 

in vitro site directed mutagenesis. 

bioRxiv 2020. doi: https://doi.org/ 

10.1101/2020.05.16.100107. 

• A restriction-free method for gene 

reconstitution. bioRxiv 2020. doi: 

https://doi.org/10.1101/ 

2020.05.20.107631. 

• Efficient Method for Protein 

Crystallization. bioRxiv 2020. doi: 

https://doi.org/10.1101/ 

2020.05.24.113860. 

• Rice Tolerance to Drought is 

Complex Both Physiologically and 

Genetically. bioRxiv 2020. doi: https://

doi.org/10.1101/2020.08.19.258293. 

• ITS2 Pretrial Gene Identification 

Related to Seed and Flower 

Identification for Cyclea barbata. 

bioRxiv 2020. doi: https://doi.org/ 

10.1101/2020.08.20.259804. 

Manuscripts Submitted to bioRxiv in 

2020 and Not Published 

• Analysis of the Deduced Amino 

Acid Sequence of Lectin-like Protein. 

• Comprehensive proteomic 

characterization of ovarian tumors. 

• Insight into the membrane protein 

localization and antibiotic resistance by 

fluorescence microscopy. 

• Invariant States of the Algebra of 

Observables. 

• The Biochemical Analysis the 

Expression Levels of Pre-synaptic, Postsynaptic, Nuclear and Mitochondrial 

Markers. 

• The Overall Difference Analysis of 

Antioxidant of Isoflavone from Three 

Kinds of Soybean Stems. 

• The Overall Difference Analysis of 

Antioxidant of Isoflavone from Three 

Kinds of Tomato. 

Manuscript Rejected by bioRxiv and 

Resubmitted to medRxiv in 2020 

• Invariant States of the Algebra of 

Observables. 

ORI finds that Respondent knowingly 

and intentionally falsified, fabricated, 

and plagiarized the whole content of six 

(6) papers and eight (8) manuscripts, 

falsely created fictitious author names 

and affiliations without listing himself 

as an author to disguise himself from 

being the offender, and submitted them 

for publication in bioRxiv and medRxiv, 

open access preprint repositories, by 

falsely assembling random paragraphs 

of text, tables, and figures from previous 

publications and manuscripts to 

improve his citation metrics. 

Dr. Lin entered into a Voluntary 

Exclusion Agreement (Agreement) and 

agreed to the following: 

(1) Because the Respondent also 

attempted to deceive the online 

publication sites bioRxiv and medRxiv 

by creating fictitious author names and 

affiliations without listing himself as an 

author, Respondent agreed to exclude 

himself voluntarily for a period of ten 

(10) years beginning on January 7, 2021, 

from any contracting or subcontracting 

with any agency of the United States 

Government and from eligibility for or 

involvement in nonprocurement 

programs of the United States 

Government referred to as ‘‘covered 

transactions’’ pursuant to HHS’ 

Implementation (2 CFR part 376) of 

OMB Guidelines to Agencies on 

Governmentwide Debarment and 

Suspension, 2 CFR part 180 (collectively 

the ‘‘Debarment Regulations’’); and 

(2) Respondent agreed to exclude 

himself voluntarily from serving in any 

advisory capacity to PHS including, but 

not limited to, service on any PHS 

advisory committee, board, and/or peer 

review committee, or as a consultant for 

a period of ten (10) years, beginning on 

January 7, 2021. 

Dated: January 29, 2021. 

Wanda K. Jones, 

Acting Director, Office of Research Integrity, 

Office of the Assistant Secretary for Health. 

[FR Doc. 2021–02273 Filed 2–3–21; 8:45 am] 

BILLING CODE 4150–31–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Library of Medicine; Notice of 

Closed Meetings 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable materials, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 


jbell on DSKJLSW7X2PROD with NOTICES